Research
Hormonal
Tirzepatide (TZP) offers superior efficacy in reducing glycemic levels and body weight compared to existing therapies.
Practitioners may consider TZP as a more effective treatment option for patients struggling to achieve glycemic control and weight loss.
StrongSupportsmedium confidence
Its unique mechanism of action offers superior efficacy in reducing glycemic levels and body weight compared to existing therapies.
Why this rating
The claim is based on a systematic review of multiple databases.
Source
Tirzepatide: unveiling a new dawn in dual-targeted diabetes and obesity management
Syed Arman Rabbani et al. · Expert Review of Endocrinology & Metabolism · 2024
reviewCited 5×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →